Stay updated on CLN-049 in AML/MDS Relapsed/Refractory Clinical Trial
Sign up to get notified when there's something new on the CLN-049 in AML/MDS Relapsed/Refractory Clinical Trial page.

Latest updates to the CLN-049 in AML/MDS Relapsed/Refractory Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 was added to the study record history. The funding-status banner and the previous revision v3.4.1 were removed.SummaryDifference0.8%

- Check21 days agoChange DetectedAdded a government funding notice about operating status and the latest revision tag (v3.4.1); removed the previous revision tag (v3.4.0).SummaryDifference0.8%

- Check28 days agoChange DetectedThe history view now includes a glossary toggle and color-coded change indicators (green for additions, red for deletions) with an updated revision note (v3.4.0). The older revision note (v3.3.4) and No FEAR Act data entry are removed.SummaryDifference1%

- Check35 days agoChange DetectedVersion history shows new entries on 2026-01-16 for Contacts/Locations and Study Status. A prior version dated 2025-11-25 was removed.SummaryDifference0.5%

- Check42 days agoChange DetectedThe history now shows Revision: v3.3.4 added and Revision: v3.3.3 removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedA new record version (Revision: v3.3.3) was added and an older revision (Revision: v3.3.2) along with the HHS Vulnerability Disclosure link were removed from the page footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to CLN-049 in AML/MDS Relapsed/Refractory Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CLN-049 in AML/MDS Relapsed/Refractory Clinical Trial page.